Genesys [GENESYS] vs Nucleus Software [NUCLEUS] Detailed Stock Comparison

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Genesys International Corporation Ltd. wins in 4 metrics, Nucleus Software Exports Ltd. wins in 14 metrics, with 0 ties. Nucleus Software Exports Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Genesys International Corporation Ltd. Nucleus Software Exports Ltd. Better
P/E Ratio (TTM) 27.56 14.31 Nucleus Software Exports Ltd.
Price-to-Book Ratio 1.61 2.47 Genesys International Corporation Ltd.
Debt-to-Equity Ratio 21.42 0.93 Nucleus Software Exports Ltd.
PEG Ratio -0.29 -0.35 Genesys International Corporation Ltd.
EV/EBITDA 10.89 10.67 Nucleus Software Exports Ltd.
Profit Margin (TTM) 12.32% 16.70% Nucleus Software Exports Ltd.
Operating Margin (TTM) -1.40% 13.13% Nucleus Software Exports Ltd.
EBITDA Margin (TTM) N/A 13.13% N/A
Return on Equity 10.09% 20.02% Nucleus Software Exports Ltd.
Return on Assets (TTM) 7.23% 14.14% Nucleus Software Exports Ltd.
Free Cash Flow (TTM) $-1.07B $1.36B Nucleus Software Exports Ltd.
Dividend Yield N/A 1.08% N/A
1-Year Return -53.00% -36.52% Nucleus Software Exports Ltd.
Price-to-Sales Ratio (TTM) 3.49 2.38 Nucleus Software Exports Ltd.
Enterprise Value $12.05B $17.27B Nucleus Software Exports Ltd.
EV/Revenue Ratio 3.79 1.96 Nucleus Software Exports Ltd.
Gross Profit Margin (TTM) 35.62% 34.16% Genesys International Corporation Ltd.
Revenue per Share (TTM) $77 $334 Nucleus Software Exports Ltd.
Earnings per Share (Diluted) $9.64 $55.74 Nucleus Software Exports Ltd.
Beta (Stock Volatility) -0.59 -0.17 Genesys International Corporation Ltd.

Genesys International Corporation Ltd. vs Nucleus Software Exports Ltd. Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Genesys International Corporation Ltd.-0.76%18.58%51.01%14.59%-25.06%-25.68%
Nucleus Software Exports Ltd.-1.51%6.34%-5.29%-1.84%-20.21%-19.81%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Genesys International Corporation Ltd.-53.00%-1.49%177.47%383.19%42.50%4,362.08%
Nucleus Software Exports Ltd.-36.52%-32.94%29.06%265.00%788.00%437.25%

Performance & Financial Health Analysis: Genesys International Corporation Ltd. vs Nucleus Software Exports Ltd.

MetricGENESYSNUCLEUS
Market Information
Market Cap i₹11.73B₹20.83B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i387,36941,580
90 Day Avg. Volume i626,05568,471
Last Close₹315.30₹739.50
52 Week Range₹198.05 - ₹702.05₹690.00 - ₹1,242.40
% from 52W High-55.09%-40.48%
All-Time High₹1,055.00 (Jan 20, 2025)₹1,787.50 (Jan 22, 2024)
% from All-Time High-70.11%-58.63%
Growth Metrics
Quarterly Revenue Growth-0.15%0.07%
Quarterly Earnings Growth-0.95%-0.41%
Financial Health
Profit Margin (TTM) i0.12%0.17%
Operating Margin (TTM) i-0.01%0.13%
Return on Equity (TTM) i0.10%0.20%
Debt to Equity (MRQ) i21.420.93
Cash & Liquidity
Book Value per Share (MRQ)₹164.56₹322.51
Cash per Share (MRQ)₹24.03₹141.09
Operating Cash Flow (TTM) i₹-1,066,629,000₹2.28B
Levered Free Cash Flow (TTM) i₹562.23M₹1.63B
Dividends
Last 12-Month Dividend Yield iN/A1.08%
Last 12-Month Dividend i₹0.00₹12.50

Valuation & Enterprise Metrics Analysis: Genesys International Corporation Ltd. vs Nucleus Software Exports Ltd.

MetricGENESYS (Apr 24, 2026)NUCLEUS (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i27.5614.31
Forward P/E i19.5412.54
PEG Ratio i-0.29-0.35
Price to Sales (TTM) i3.492.38
Price to Book (MRQ) i1.612.47
Market Capitalization
Market Capitalization i₹11.73B₹20.83B
Enterprise Value i₹12.05B₹17.27B
Enterprise Value Metrics
Enterprise to Revenue i3.791.96
Enterprise to EBITDA i10.8910.67
Risk & Other Metrics
Beta i-0.59-0.17
Book Value per Share (MRQ) i₹164.56₹322.51

Financial Statements Comparison: Genesys International Corporation Ltd. vs Nucleus Software Exports Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricGENESYS (2025)NUCLEUS (2025)
Revenue/Sales i3.11B8.32B
Cost of Goods Sold i1.34B5.50B
COGS % of Revenue i43.1%66.1%
Gross Profit i1.77B2.82B
Gross Margin i56.9%33.9%
Research & Development iN/AN/A
Operating Income (EBIT) i910.69M1.54B
Operating Margin i29.3%18.4%
EBITDA i1.49B1.95B
EBITDA Margin i48.0%23.4%
Pre-Tax Income i826.76M2.19B
Pre-Tax Income % of Revenue i26.6%26.3%
Income Tax i265.73M560.50M
Income Tax % of Revenue i8.5%6.7%
Net Income (Profit) i561.04M1.63B
Profit Margin i18.0%19.6%

Balance Sheet & Liquidity Metrics

MetricGENESYS (2025)NUCLEUS (2025)
Cash & Equivalents i33.44M501.60M
Total Current Assets i4.55B5.44B
Total Current Assets % of Revenue i146.3%65.4%
Total Current Liabilities i1.89B2.83B
Total Current Liabilities % of Revenue i60.8%34.0%
Long-Term Debt i222.61M8.80M
Long-Term Debt % of Revenue i7.2%0.1%
Total Shareholders Equity i5.57B8.14B
Retained Earnings i1.30B7.67B
Retained Earnings % of Revenue i41.9%92.1%
Property, Plant & Equipment i825.12M470.30M

Cash Flow Statement Comparison

MetricGENESYS (2025)NUCLEUS (2025)
Operating Cash Flow i-1.07B2.28B
Operating Cash Flow % of Revenue i-34.3%27.3%
Capital Expenditures i-433.71M-152.20M
Free Cash Flow i-1.07B1.36B
FCF Margin i-34.4%16.3%
Debt Repayment i-97.00MN/A
Common Stock Repurchase iN/A-892.10M

Short Interest & Institutional Ownership Analysis

MetricGENESYSNUCLEUS
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i41.79M26.33M
Float Shares i23.41M6.90M
% Held by Insiders i45.13%75.61%
% Held by Institutions i2.49%2.48%
% Held by Public i52.38%21.91%

Dividend Analysis & Yield Comparison: Genesys International Corporation Ltd. vs Nucleus Software Exports Ltd.

MetricGENESYSNUCLEUS
Last 12-Month Dividend i₹0.00₹12.50
Last 12-Month Dividend Yield iN/A1.08%
3-Year Avg Annual Dividend i₹0.00₹11.67
3-Year Avg Dividend Yield iN/A0.93%
3-Year Total Dividends i₹0.00₹35.00
Ex-Dividend DateN/AJul 11, 2025